ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer

ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer

Lung cancer is one of most actual problem of modern oncology. The III-IV stages of non-small cell lung cancer (NSCLC) in Zaporizhzhia region are diagnosed in more than 75 % of patients. Chemotherapy is a standard of advanced NSCLC treatment. But results of such treatment are still unsatisfactory due...

Full description

Bibliographic Details
Main Authors: O. P. Kolesnik, V. O. Kuzmenko
Format: Article
Language:English
Published: Zaporozhye State Medical University 2020-06-01
Series:Patologìâ
Subjects:
non-small cell lung cancer
prognostic factors
predictive markers
ercc1
survival
Online Access:http://pat.zsmu.edu.ua/article/view/203639/204689

Similar Items

Similar Items